Multiple Compounds Secreted by Pseudomonas aeruginosa Increase the Tolerance of Staphylococcus aureus to the Antimicrobial Metals Copper and Silver
Open Access
- 27 October 2020
- journal article
- research article
- Published by American Society for Microbiology in mSystems
- Vol. 5 (5)
Abstract
Metal-based antimicrobials have been used for thousands of years to treat and prevent bacterial infections. Currently, both silver and copper are used in health care and industry to prevent and treat the spread of harmful bacteria. However, like most antimicrobial agents, their efficacy against polymicrobial infections has not been fully elucidated. Coinfection with Pseudomonas aeruginosa and Staphylococcus aureus and the resulting interactions have been implicated in higher virulence, antibiotic resistance, and increased chronic infections. Here, the influence of secreted compounds from P. aeruginosa on metal antimicrobial tolerance in S. aureus was examined. This study determined that multiple compounds from P. aeruginosa increase the tolerance of S. aureus to copper and/or silver when cultured in simulated wound fluid. The presence of these secreted compounds from P. aeruginosa during exposure of S. aureus to copper or silver increased the MIC from 500 μM to 2,000 μM for copper and 16 to 63 μM for silver. The contribution of specific compounds to S. aureus tolerance was determined using gene deletion and disruption mutants, and metabolite analysis. Compounds identified as potential contributors were then individually added to S. aureus during metal exposure. Copper tolerance in S. aureus was found to be increased by amino acids and dihydroaeruginoate (Dha) secreted by P. aeruginosa. The silver tolerance provided to S. aureus was influenced only by two amino acids, serine and threonine, as well as the Pseudomonas quinolone signal (PQS) molecules from P. aeruginosa. IMPORTANCE Alternative antimicrobials, such as metals, are one of the methods currently used to help mitigate antibiotic resistance. Metal-based antimicrobials such as copper and silver are used currently both to prevent and to treat infections. Although the efficacy of these antimicrobials has been determined in single-species culture, bacteria rarely exist in a single-species group in the environment. Both Pseudomonas aeruginosa and Staphylococcus aureus are often found associated with each other in severe chronic infections displaying increased virulence and antibiotic tolerance. In this study, we determined that multiple compounds secreted by P. aeruginosa are able to increase the tolerance of S. aureus to both copper and silver. This work demonstrates the expansive chemical communication occurring in polymicrobial infections between bacteria.Keywords
Funding Information
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
This publication has 55 references indexed in Scilit:
- Antimicrobial Resistance in ESKAPE PathogensClinical Microbiology Reviews, 2020
- Metal-Based Nanoparticles as Antimicrobial Agents: An OverviewNanomaterials, 2020
- High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?Canadian Journal of Gastroenterology and Hepatology, 2019
- The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and TechnologiesAntibiotics, 2019
- Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017)Antibiotics, 2018
- Antimicrobial resistance challenged with metal-based antimicrobial macromoleculesBiomaterials, 2017
- Countering drug resistance, infectious diseases, and sepsis using metal and metal oxides nanoparticles: Current statusColloids and Surfaces B: Biointerfaces, 2016
- Silver in medicine: A brief history BC 335 to presentBurns, 2014
- Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteriaCurrent Opinion in Pulmonary Medicine, 2008
- Risk Factors for the Spread of Antibiotic-Resistant BacteriaDrugs, 1998